Recombinant Human Bone Morphogenetic Protein-2(rhBMP-2) in Patients With Osteoporosis After Lumbar Fusion
Clinical trial NCT05911477 · UNKNOWN
Trial details
- NCT number
- NCT05911477
- Sponsor
- Xijing Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-01
- Primary completion
- 2023-12-31
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.